782 related articles for article (PubMed ID: 25607108)
1. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
2. [MGRS - monoclonal gammopathy of renal significance].
Wieliczko M; Matuszkiewicz-Rowińska J
Wiad Lek; 2017; 70(6 pt 2):1175-1178. PubMed ID: 29533908
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
Ciocchini M; Arbelbide J; Musso CG
Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
[TBL] [Abstract][Full Text] [Related]
4. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
5. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
[TBL] [Abstract][Full Text] [Related]
9. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
Sethi S; Rajkumar SV; D'Agati VD
J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performances of M-protein tests according to the clinical presentations of kidney disease.
Koo EH; Shin JH; Jang HR; Park HD; Kwon GY; Huh W; Kim DJ; Kim YG; Oh HY; Lee JE
Eur J Intern Med; 2016 Sep; 33():88-92. PubMed ID: 27421913
[TBL] [Abstract][Full Text] [Related]
11. An update to the pathogenesis for monoclonal gammopathy of renal significance.
Zuo C; Zhu Y; Xu G
Crit Rev Oncol Hematol; 2020 May; 149():102926. PubMed ID: 32199132
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.
Liu J; Liang D; Liang S; Xu F; Huang X; Jiang S; Hou J
Sci Rep; 2022 Oct; 12(1):16994. PubMed ID: 36216844
[TBL] [Abstract][Full Text] [Related]
13. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
[TBL] [Abstract][Full Text] [Related]
14. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of renal significance with light-chain deposition disease diagnosed postrenal transplant: a diagnostic and therapeutic challenge.
Nambirajan A; Bhowmik D; Singh G; Agarwal SK; Dinda AK
Transpl Int; 2015 Mar; 28(3):375-9. PubMed ID: 25441103
[TBL] [Abstract][Full Text] [Related]
16. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
17. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
Gomes-Alves I; Castro-Ferreira I
Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.
Leung N; Bridoux F; Batuman V; Chaidos A; Cockwell P; D'Agati VD; Dispenzieri A; Fervenza FC; Fermand JP; Gibbs S; Gillmore JD; Herrera GA; Jaccard A; Jevremovic D; Kastritis E; Kukreti V; Kyle RA; Lachmann HJ; Larsen CP; Ludwig H; Markowitz GS; Merlini G; Mollee P; Picken MM; Rajkumar VS; Royal V; Sanders PW; Sethi S; Venner CP; Voorhees PM; Wechalekar AD; Weiss BM; Nasr SH
Nat Rev Nephrol; 2019 Jan; 15(1):45-59. PubMed ID: 30510265
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
